z-logo
open-access-imgOpen Access
PK/PD considerations when treating MRSA
Author(s) -
Teresita Mazzei
Publication year - 2012
Publication title -
international journal of infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2012.05.135
Subject(s) - teicoplanin , pharmacokinetics , medicine , linezolid , pharmacodynamics , vancomycin , antibiotics , cmax , pharmacology , dose , antimicrobial , minimum inhibitory concentration , drug , therapeutic drug monitoring , sepsis , intensive care medicine , staphylococcus aureus , chemistry , biology , biochemistry , organic chemistry , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom